| 000 | 01136 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250517034222.0 | ||
| 264 | 0 | _c20150605 | |
| 008 | 201506s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1504241 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoore, Halle C F | |
| 245 | 0 | 0 |
_aOvarian protection during adjuvant chemotherapy. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c06 2015 |
||
| 300 |
_a2269-70 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xagonists |
| 650 | 0 | 4 |
_aGoserelin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPrimary Ovarian Insufficiency _xprevention & control |
| 700 | 1 | _aUnger, Joseph M | |
| 700 | 1 | _aAlbain, Kathy S | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 372 _gno. 23 _gp. 2269-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1504241 _zAvailable from publisher's website |
| 999 |
_c24948158 _d24948158 |
||